Ulcerative Colitis Serum

In Stock Samples

Lot # Condition Volume Race/Ethnicity Age Gender Country of Collection Medications Vials Price Action
74062 Ulcerative Colitis 1.0 ML Caucasian 45 Male United States
Lialda QD, Stelara Q4 weeks
3 $316.00
74064 Ulcerative Colitis 1.0 ML Caucasian 45 Female United States
Rinvoq 15 mg once a day, Protonix 40mg QD Famotidine 40 mg BID Metronidazole cream- for rosacea - topical Ventolin Inhaler 2 puffs PRN Lexapro 10mg QD Ozempic 2mg injection QD for weight loss Adderall 40mg QD
5 $316.00
74066 Ulcerative Colitis 1.0 ML Caucasian 33 Female United States
Remicade Q6 weeks Loestren birth control QD
6 $316.00
74070 Ulcerative Colitis 1.0 ML Caucasian 37 Male United States
Mesalamine 1.2 mg QID
2 $316.00
74068 Ulcerative Colitis 1.0 ML African American 40 Female United States
Sertraline 100 mg QD Topamax 50 mg QD Famotidine 10 mg QD Buspar 3.5 mg QD- no longer taking Remicade IV Q6W Crestor 5 mg QD Klonopin 0.5 mg PRN Hydroxyzine 25 mg PRN Zofran PRN
6 $316.00
74061 Ulcerative Colitis 1.0 ML Caucasian 70 Female United States
Balsalazide (Colazal) 750mg, 3 per day Levothyroxine/Synthroid 0.100 mcg QD Pantoprazole 40 mg QD
3 $316.00
74067 Ulcerative Colitis 1.0 ML Caucasian 30 Female United States
Nexplanon BC implant
3 $316.00

Human Ulcerative Colitis Serum for Research

Our Ulcerative Colitis Serum is sourced from IRB-consented donors clinically diagnosed with ulcerative colitis. Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for biomarker discovery and cytokine profiling.

Product Features

  • Collected from clinically confirmed ulcerative colitis donors
  • Research Use Only (RUO)
  • IRB-approved protocols with documented consent

De-identified Donor Data

  • Diagnosis confirmation
  • Age, sex assigned at birth, and ethnicity
  • Donor-reported allergy and infectious disease history

Applications

  • Biomarker discovery for ulcerative colitis
  • Serum cytokine and protein profiling
  • Therapeutic candidate screening and validation

Compliance and Quality Assurance

  • IRB-approved and HIPAA-compliant protocols
  • Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
  • Documentation support available for regulatory review

Ordering and Customization

Ulcerative Colitis serum is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.

Protocols & Documentation

  • Serum Isolation

    Protocol for serum preparation from whole blood, including collection handling, clarification, and quality documentation.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

Serum

Frequently Asked Questions

×

Ask a Question

Need a custom Serum cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information